Dr. Spencer K. Sullivan, MD

Dr. Sullivan practices at Quest Diagnostics Clinical Laboratories Inc in Madison, Mississippi.

Dr. Sullivan's NPI, 1073735114, was assigned on May 2, 2007. Dr. Sullivan graduated from University of North Carolina at Chapel Hill School of Medicine in 2005. Dr. Sullivan holds Mississippi license 23304.

Dr. Sullivan's primary practice is Quest Diagnostics Clinical Laboratories Inc, at 7731 Old Canton Rd, Madison, MS 39110 in Madison County. The practice phone is (713) 877-6000.

Dr. Sullivan's primary practice is Quest Diagnostics Clinical Laboratories Inc in Madison, Mississippi. The medical group on file is Baptist Medical Clinics.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sullivan practices. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Sullivan's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Sullivan is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dr. Sullivan is licensed in Mississippi.

CMS data shows 66 Medicare services from Dr. Sullivan across 3 procedure codes in 2024, for 38 Medicare patients. Medicare paid $3,686 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Dr. Sullivan in 2024. The largest group is under 65, with 22 patients. 63% of them have high blood pressure, and 58% have arthritis. 45% are also on Medicaid. Their average risk score is 4.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sullivan's median patient age at 22, with 50% women.

In 2024, Dr. Sullivan wrote 544 Medicare Part D claims for 38 patients. 84% of them were for generic drugs. CMS names the drug for 466 of them, across 14 drugs with 11 or more claims each, at $532,008 in total drug cost. In 2023, CMS named 294 claims across 9 drugs.

Dmand AI links 18 papers to Dr. Sullivan, published from 2012 to 2021. 2013 was the busiest year, with 5. The most frequent topics are Blood Platelets, Megakaryocytes and Induced Pluripotent Stem Cells. Dr. Sullivan has published most often in Blood. Dr. Sullivan's most frequent co-authors are Stella T. Chou, MD, Mitchell J. Weiss, MD and Kristin Mara Hudock, MD.

Dmand AI links Dr. Sullivan to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hemophilia A, Hemophilia B and Coagulation Protein Disorders.

CMS Open Payments shows 111 general payments to Dr. Sullivan from 14 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 45% of the total. BioMarin Pharmaceutical Inc. paid the most, $38,673. It also lists 13 research payments totaling $18,122 from 2018 to 2023.

Dr. Sullivan graduated from University of North Carolina at Chapel Hill School of Medicine in 2005.